New bioactive metabolites from the elicited marine sponge-derived bacterium Actinokineospora spheciospongiae sp. nov.
Tawfike, Ahmed and Attia, Eman Zekry and Desoukey, Samar Yehia and Hajjar, Dina and Makki, Arwa A. and Schupp, Peter J. and Edrada-Ebel, RuAngelie and Abdelmohsen, Usama Ramadan (2019) New bioactive metabolites from the elicited marine sponge-derived bacterium Actinokineospora spheciospongiae sp. nov. AMB Express, 9 (1). ISSN 2191-0855 (https://doi.org/10.1186/s13568-018-0730-0)
Preview |
Text.
Filename: Tawfike_etal_AMBE2018_New_bioactive_metabolites_from_the_elicited_marine_sponge_derived.pdf
Final Published Version License: Download (1MB)| Preview |
Abstract
Several approaches have been dedicated to activate the cryptic gene clusters in the genomes of actinomycetes for the targeted discovery of new fascinating biomedical lead structures. In the current study, N-acetylglucosamine was used to maximize the chemical diversity of sponge-derived actinomycete Actinokineospora spheciospongiae sp. nov. HR–ESI–MS was employed for dereplication study and orthogonal partial least square-discriminant analysis was applied to evaluate the HR–ESI–MS data of the different fractions. As a result, two new fridamycins H (1) and I (2), along with three known compounds actinosporin C (3), D (4), and G (5) were isolated from the solid culture of sponge-associated actinomycete Actinokineospora spheciospongiae sp. nov., elicited with N-acetylglucosamine. Characterization of the isolated compounds was pursued using mass spectrometry and NMR spectral data. Fridamycin H (1) exhibited significant growth inhibitory activity towards Trypanosoma brucei strain TC221. These results highlight the potential of elicitation in sponge-associated actinomycetes as an effective strategy for the discovery of new anti-infective natural products.
ORCID iDs
Tawfike, Ahmed ORCID: https://orcid.org/0000-0003-2061-3093, Attia, Eman Zekry, Desoukey, Samar Yehia, Hajjar, Dina, Makki, Arwa A., Schupp, Peter J., Edrada-Ebel, RuAngelie and Abdelmohsen, Usama Ramadan;-
-
Item type: Article ID code: 66963 Dates: DateEvent24 January 2019Published31 December 2018AcceptedSubjects: Medicine > Therapeutics. Pharmacology Department: Faculty of Science > Strathclyde Institute of Pharmacy and Biomedical Sciences Depositing user: Pure Administrator Date deposited: 14 Feb 2019 11:19 Last modified: 22 Nov 2024 18:58 Related URLs: URI: https://strathprints.strath.ac.uk/id/eprint/66963